成人椎间盘炎分子影像:当前证据、临床应用与未来展望
本文综述成人椎间盘炎分子影像的现有证据与临床应用。[18F]FDG PET/CT 是最成熟的分子影像技术,诊断性能高、可全身评估,并在 MRI 禁忌、结果不明确或术后难判读时支持管理;但其病原体特异性有限、 sterile炎症可摄取、判读标准不一且治疗监测阈值不确定。PET/MRI、FAPI 示踪剂、病原体靶向放射性药物、定量 PET 生物标志物和 AI 等新方法仍处于研究阶段,需前瞻性验证。
要点
- [18F]FDG PET/CT 是椎间盘炎最成熟的分子影像技术。
- MRI 仍为一线解剖学检查,CT 用于骨破坏、不稳和活检引导。
- 分子影像可补充结构成像,但病原体特异性有限。
核心结论
- [18F]FDG PET/CT 是成人椎间盘炎最成熟的分子影像技术,诊断性能高并可全身评估。
- 新兴分子影像方法仍处于研究阶段,需前瞻性验证诊断和临床效用。
研究设计与样本
- 本文为综述,总结成人椎间盘炎分子影像的当前证据、临床应用、局限性和未来方向。
主要发现
- [18F]FDG PET/CT 在 MRI 禁忌、结果不明确或术后难判读时支持管理。
- [18F]FDG PET/CT 主要局限包括病原体特异性有限、无菌性炎症或修复过程可摄取、判读标准不一及治疗监测阈值不确定。
- PET/MRI、FAPI 示踪剂、病原体靶向放射性药物、定量 PET 生物标志物和 AI 等新方法仍处于研究阶段。
关键数值与推荐
- MRI 仍为早期骨髓、椎间盘、硬膜外和椎旁病变的一线解剖学技术。
- CT 对骨破坏、不稳和活检引导有价值。
临床怎么用
- 临床怀疑成人椎间盘炎时,MRI 作为一线解剖学检查,CT 用于评估骨破坏、不稳和引导活检。
- 当 MRI 禁忌、结果不明确或术后难判读时,可考虑 [18F]FDG PET/CT 辅助诊断和全身评估。
- 解读 [18F]FDG PET/CT 时需注意无菌性炎症或修复过程可导致摄取,治疗监测阈值尚不确定。
局限性
- [18F]FDG PET/CT 病原体特异性有限,判读标准不一,治疗监测阈值不确定。
- 新兴分子影像方法仍需前瞻性验证诊断和临床效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adult spondylodiscitis is an infection of the intervertebral disc and adjacent vertebral bodies that may progress to paravertebral extension, epidural involvement, spinal instability, sepsis, and neurological compromise. Because clinical symptoms and laboratory markers are often nonspecific, imaging is central to diagnosis, assessment of disease extent, biopsy planning, and selective evaluation of treatment response. Magnetic resonance imaging (MRI) remains the first-line anatomical technique for early marrow, disc, epidural, and paraspinal disease, while computed tomography (CT) is valuable for osseous destruction, instability, and biopsy guidance. Molecular imaging complements these modalities by depicting biological activity rather than structure alone. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) is the most established molecular technique, offering high diagnostic performance, whole-body evaluation for multifocal or metastatic infection, and support for management when MRI is contraindicated, equivocal, or difficult to interpret after surgery. Its main limitations are limited pathogen specificity, uptake in sterile inflammatory or reparative processes, heterogeneous interpretation criteria, and uncertain thresholds for treatment monitoring. Emerging approaches, including hybrid positron emission tomography/magnetic resonance imaging (PET/MRI), fibroblast activation protein inhibitor (FAPI) tracers, pathogen-targeted radiopharmaceuticals, quantitative PET biomarkers, and artificial intelligence (AI), remain investigational and require prospective validation of diagnostic and clinical utility. This review summarizes current evidence, clinical applications, limitations, and future directions for molecular imaging in spondylodiscitis.
引用
- Al-Ibraheem A, Estrada-Lobato E, Ruzzeh S, et al. Molecular imaging in adult spondylodiscitis: current evidence, clinical applications, and future perspectives. Semin Nucl Med. 2026. PMID: 42951721. doi:10.1053/j.semnuclmed.2026.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。